MedPath

Arteriopathy and Endothelial Function

Not Applicable
Conditions
Peripheral Arterial Disease
Registration Number
NCT00487617
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

To determine whether fruit juice might reverse endothelial dysfunction and whether this reversibility has a prognosis value

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Peripheral arteriopathy
  • Stable cardio-respiratory status
Exclusion Criteria
  • Dialysis

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Endothelial function 1 hour after taking the juice1 hour after taking the juice
Secondary Outcome Measures
NameTimeMethod
Relationship between reversibility of the endothelial function and the patient's prognosis at 3 years3 years

Trial Locations

Locations (2)

Service de Chirurgie Vasculaire

🇫🇷

Strasbourg, France

Service de Physiologie et d'Explorations Fonctionnelles

🇫🇷

Strasbourg, France

Service de Chirurgie Vasculaire
🇫🇷Strasbourg, France
Fabien Thaveau, MD
Principal Investigator
Nabil Chakfe, MD
Sub Investigator
Jean-Georges Kretz, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.